Maplight Therapeutics, Common Stock Net Income
| MPLT Stock | 18.01 0.11 0.61% |
MapLight Therapeutics,'s fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting MapLight Stock price.
Net Loss is likely to drop to -1.97 in 2025. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. MapLight Therapeutics, Common Company Net Income Analysis
MapLight Therapeutics,'s Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
MapLight Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for MapLight Therapeutics, is extremely important. It helps to project a fair market value of MapLight Stock properly, considering its historical fundamentals such as Net Income. Since MapLight Therapeutics,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of MapLight Therapeutics,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of MapLight Therapeutics,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
MapLight Net Income Per Share
Net Income Per Share |
|
Based on the recorded statements, MapLight Therapeutics, Common reported net income of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The net income for all United States stocks is 100.0% higher than that of the company.
MapLight Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MapLight Therapeutics,'s direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MapLight Therapeutics, could also be used in its relative valuation, which is a method of valuing MapLight Therapeutics, by comparing valuation metrics of similar companies.MapLight Therapeutics, is currently under evaluation in net income category among its peers.
About MapLight Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MapLight Therapeutics, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MapLight Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MapLight Therapeutics, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MapLight Stock Analysis
When running MapLight Therapeutics,'s price analysis, check to measure MapLight Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MapLight Therapeutics, is operating at the current time. Most of MapLight Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of MapLight Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MapLight Therapeutics,'s price. Additionally, you may evaluate how the addition of MapLight Therapeutics, to your portfolios can decrease your overall portfolio volatility.